GARDNER PHYLLIS
Known title: DirectorCIK: 0001238646
Associated companies
Transaction History
| MDXG | ▲ Buy | Grant | 35,354 | $175K | 6/13/2023 | View on chart |
| MDXG | ▲ Buy | Grant | 44,191 | $175K | 6/7/2022 | View on chart |
| MDXG | ▲ Buy | Grant | 35,354 | $175K | 6/13/2023 | View on chart |
| MDXG | ▲ Buy | Grant | 44,191 | $175K | 6/7/2022 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
MiMedx merger faces FTC second request
MiMedx and Sanara have received a second request from the U.S. Federal Trade Commission for additional information regarding their proposed business combination. This regulatory step adds uncertainty to the merger timeline. The stock is currently trading near its 52-week low, reflecting the ongoing scrutiny.
MiMedx merger faces FTC second request. MiMedx and Sanara have received a second request from the U.S. Federal Trade Commission for additional information regarding their proposed business combination. This regulatory step adds uncertainty to the merger timeline. The stock is currently trading near its 52-week low, reflecting the ongoing scrutiny.